ARCHIVES

Drug pricing: Amgen’s “bundling” violates antitrust laws, J&J claims in suit.

This article is from The Cancer Letter archive.

Vol. 31 No. 37 | October 14, 2005

Download PDF Visit The Full Archive

Related Articles

New Biologic Modalities Show Promise In Treatment Of Lymphomas, Research Finds

June 28, 2002

Obama Plan Would Double Cancer Funding, Increase Clinical Trial Enrollment To 10%.

November 7, 2008

New Immunotherapy Increased Survival Of Neuroblastoma In Phase III Trial

September 24, 2010

NCI-Approved CTEP Trials For The Month of June

June 29, 2012

DePinho Seeks New Review of Incubator Proposal

June 1, 2012

FDA, Companies Fail To Collect COI Forms, Report Says

January 16, 2009